| Dr William Moneit, | |
|
2925 Premiere Pkwy, Suite #140, Duluth, GA 30097 | |
| (770) 495-6222 | |
| (770) 495-9959 |
| Full Name | Dr William Moneit |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 2925 Premiere Pkwy, Duluth, Georgia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316944671 | NPI | - | NPPES |
| 000449611C | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 034204 (Georgia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr William Moneit, 2925 Premiere Pkwy, Suite #140, Duluth, GA 30097 Ph: (770) 495-6222 | Dr William Moneit, 2925 Premiere Pkwy, Suite #140, Duluth, GA 30097 Ph: (770) 495-6222 |
News Archive
Led by King's College London in collaboration with the University of Zimbabwe and the London School of Hygiene & Tropical Medicine, and published in The Lancet's EClinicalMedicine journal, the research examined a group of people with depression in Zimbabwe and found that people are nearly three times more likely to suffer this illness long-term if they also have a high level of anxiety.
Hospira announced today that the EC has approved Nivestim™ (filgrastim) for the prevention of FN, the most serious haematological toxicity that occurs as a result of cancer chemotherapy. Nivestim now has marketing authorisation in all EU member states. Nivestim is expected to reduce the cost of neutropenia treatment.
Osiris Therapeutics, Inc. today announced that it is resuming enrollment in its clinical trial evaluating Prochymal for patients with treatment-resistant Crohn's disease. The findings of an interim analysis showed that for the primary endpoint of disease remission, Prochymal is approaching statistical significance in the intent to treat (ITT) population, and has reached significance in the per protocol population.
The United States Food and Drug Administration (FDA) is looking again at the safety of a drug Nuplazid that was approved earlier in 2016. This is the only drug that has been approved for the treatment of psychiatric manifestations such as hallucinations and delusions that are associated with Parkinson's disease.
› Verified 7 days ago
Linda H Remlinger, CNP Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3650 Steve Reynolds Blvd, Pediatrics Health Care Team A, Duluth, GA 30096 Phone: 770-931-6012 | |
Dr. Aparna V Peethambaram, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1815 Satellite Blvd, #501, Duluth, GA 30097 Phone: 678-496-2600 Fax: 888-226-8819 | |
Kimberly N Hodge-spears, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 3625 Savannah Pl Ste 101a-b, Duluth, GA 30096 Phone: 770-707-4018 Fax: 770-785-4488 | |
Dr. Yejin Kim, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 3435 Duluth Park Ln, Suite A, Duluth, GA 30096 Phone: 678-417-0407 Fax: 678-417-2008 | |
Scott G Pugel, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 3650 Steve Reynolds Blvd, Pediatrics Health Care Team A, Duluth, GA 30096 Phone: 770-931-6012 | |
Dr. Farida Kwaji, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2660 Satellite Blvd, Duluth, GA 30096 Phone: 404-785-8330 | |
Andrew B Adam, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3650 Steve Reynolds Blvd, Pediatrics Health Care Team A, Duluth, GA 30096 Phone: 770-931-6010 Fax: 770-931-6005 |